Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Erratum: NLRP3 inflammasome via IL-1ß regulates PCSK9 secretion: Erratum.
Ding, Zufeng; Wang, Xianwei; Liu, Shijie; Zhou, Sichang; Kore, Rajshekhar A; Mu, Shengyu; Deng, Xiaoyan; Fan, Yubo; Mehta, Jawahar L.
Theranostics ; 12(1): 418, 2022.
Article in English | MEDLINE | ID: mdl-34987654

ABSTRACT

[This corrects the article DOI: 10.7150/thno.45939.].

2.
Eptifibatide-Induced Thrombocytopenia--When Inhibitor Turns Killer.
Pothineni, Naga Venkata; Watts, Thomas E; Ding, Zufeng; Dai, Yao; Deshmukh, Abhishek J.
Am J Ther ; 23(1): e298-9, 2016.
Article in English | MEDLINE | ID: mdl-24368608

ABSTRACT

Eptifibatide is a commonly and widely used drug for management of acute coronary syndrome and during percutaneous coronary intervention. It is usually well tolerated with no major adverse effects. We report a rare case of life-threatening thrombocytopenia secondary to eptifibatide along with a literature review of available evidence.


Subject(s)
Peptides/adverse effects , Platelet Aggregation Inhibitors/adverse effects , Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors , Thrombocytopenia/chemically induced , Aged , Eptifibatide , Humans , Male
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL